5 Am Venture Management, LLC Portfolio Holdings

5 Am Venture Management, LLC

  • $225 Million
  • Q4 2024

5 Am Venture Management, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $225 Million distributed in 31 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Entrada Therapeutics, Inc. with a value of $76.2M, Pharvaris N.V. with a value of $15.3M, Moon Lake Immunotherapeutics with a value of $15M, Viridian Therapeutics, Inc.\De with a value of $14.1M, and Centessa Pharmaceuticals PLC with a value of $13.9M.

Examining the 13F form we can see an decrease of $25.7M in the current position value, from $251M to 225M.

5 Am Venture Management, LLC is based out at San Francisco, CA

Below you can find more details about 5 Am Venture Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $225 Million
Healthcare: $225 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$410M
$76.2 Million 33.83% of portfolio
4,408,379
Q4 2021 New
$557M
$15.3 Million 6.79% of portfolio
797,600
Q4 2023 Added 35.74%
$1.55B
$15 Million 6.66% of portfolio
282,313
Q1 2024 Reduced 6.71%
$663M
$14.1 Million 6.27% of portfolio
736,595
Q1 2024 Added 25.57%
$1.58B
$13.9 Million 6.18% of portfolio
830,945
Q4 2024 Reduced 35.34%
$178M
$13.6 Million 6.02% of portfolio
5,405,404
Q2 2024 New
$536M
$13.1 Million 5.8% of portfolio
939,298
Q1 2024 Added 69.25%
$1.06B
$12.6 Million 5.58% of portfolio
497,270
Q4 2023 Added 60.27%
$216M
$7.82 Million 3.47% of portfolio
1,050,000
Q3 2024 Added 2,000.0%
$2.43B
$7.63 Million 3.39% of portfolio
189,593
Q4 2024 Reduced 20.19%
$53.3M
$7.06 Million 3.13% of portfolio
6,361,723
Q4 2021 Reduced 4.94%
$2.35B
$4.59 Million 2.04% of portfolio
165,000
Q4 2024 New
$92.1M
$4.25 Million 1.89% of portfolio
1,200,647
Q1 2023 Reduced 56.1%
$44.3M
$4.2 Million 1.86% of portfolio
800,000
Q4 2024 New
$728M
$4.01 Million 1.78% of portfolio
572,665
Q1 2024 Added 41.61%
$24.7M
$3.49 Million 1.55% of portfolio
3,630,724
Q1 2023 Reduced 2.68%
$154M
$1.88 Million 0.84% of portfolio
995,841
Q4 2024 New
$51.5M
$1.87 Million 0.83% of portfolio
1,305,000
Q2 2023 Added 10.13%
$141M
$1.48 Million 0.66% of portfolio
490,000
Q2 2023 New
Praxis Precision Medicines I
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 50.0%
Anaptysbio Inc
-
$0 0.0% of portfolio
-
Q4 2022 New
Artiva Biotherapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Biohaven LTD
-
$0 0.0% of portfolio
-
Q3 2024 Added 1.92%
Camp4 Therapeutics Corp
-
$0 0.0% of portfolio
-
Q4 2024 New
Tectonic Therapeutic Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 7.71%
Skye Bioscience Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 2.62%
Cidara Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
Dianthus Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 16.56%
Enliven Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 6.99%
Adverum Biotechnologies Inc
-
$0 0.0% of portfolio
-
Q1 2024 New

Summary

  • Portfolio
  • No. of Stocks 31
  • Current Value $225 Million
  • Prior Value $251 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 4 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track 5 Am Venture Management, LLC Portfolio

Follow 5 Am Venture Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 5 Am Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 5 Am Venture Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email